Clinical trial
An Open-label, Multiple-dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Lumateperone in Pediatric Patients, Ages 5 to Less Than 13 Years, Diagnosed With Autism Spectrum Disorder
NCT06557902 is registered in ClinicalTrials.gov with Intra-Cellular Therapies, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label, Multiple-dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Lumateperone in Pediatric Patients, Ages 5 to Less Than 13 Years, Diagnosed With Autism Spectrum Disorder
- Lead sponsor
- Intra-Cellular Therapies, Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- May 10, 2024
- Completion date
- November 26, 2025
- Enrollment
- 33 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.